Ignite Creation Date:
2025-12-25 @ 4:18 AM
Ignite Modification Date:
2025-12-26 @ 3:19 AM
Study NCT ID:
NCT00139620
Status:
COMPLETED
Last Update Posted:
2018-02-08
First Post:
2005-08-25
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Pharmacokinetic Study of Erlotinib in Cancer Patients With Advanced Solid Tumors, With Adequate and Moderately Impaired Hepatic Function
Sponsor:
OSI Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-08-22
Start Date Type:
ACTUAL
Primary Completion Date:
2007-06-25
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-06-25
Completion Date Type:
ACTUAL
First Submit Date:
2005-08-25
First Submit QC Date:
None
Study First Post Date:
2005-08-31
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-02-06
Last Update Post Date:
2018-02-08
Last Update Post Date Type:
ACTUAL